explore -WSS

explore

author：leisure time 2025-10-02 01:08:57 - browse：9

A photograph of businesses in the rural town of Bishop, California where medicare advantage plans have been advertised despite no in-network providers being available within several hundred miles. — In rural areas such as Bishop, Calif., elderly patients on Medicare Advantage plans can't find in-network providers within several hundred miles. Mario Tama/Getty Images

In the rural California town where physician Atashi Mandal sees patients, Medicare Advantage is popular among the older residents, many of whom have multiple chronic health conditions.

Problem is, there aren’t any in-network providers for several hundred miles.

“My patients seem to be unaware of this major deficiency regarding participation in Medicare Advantage plans,” Mandal wrote in a recent letter to the Centers for Medicare and Medicaid Services.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

WSS

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Artificial intelligence use in health care faces greater scrutiny in 2024

Addressing health care workers' trauma can help fight burnout

FDA poised to publish guidelines for clinical trial diversity

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Eli Lilly reports tirzepatide MASH success during Q4 earnings

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Affirmative action in medical school literally saved lives

Fentanyl is making it harder to start addiction treatment

At least 13 dead in Texas as scorching temps continue

UnitedHealth argues against case alleging wrongful AI care denials

United colonoscopy coverage change 'may cost lives,' doctors say

Scrutiny of post

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Artificial intelligence use in health care faces greater scrutiny in 2024

BioMarin wins approval for gene therapy to treat hemophilia A

Long Covid research funding gets a major boost from NIH

hotspot

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

UnitedHealth argues against case alleging wrongful AI care denials

Study gives hint on South Asians’ higher risk of cardiovascular disease

Readout Newsletter: Amylyx, Aurinia, and IQVIA

As a primary care physician, here's how I hope to partner with AI

Scrutiny of post

knowledge

leisure time

focus

knowledge